® now in commercial production
         

Crospon logo

Home
About Us
Product Brochures
EndoFLIP® Technology

Clinical Applications

- Upper GI Surgery

- Bariatric Surgery

- Upper GI Imaging

- Cardiology

- Therapeutic Endoscopy

- Colorectal Imaging

Distributors
Newsroom
Events
Contact Us



 

 

Crospon completes First Shipment to Europe

EndoFLIP® now in commercial production

Crospon commences shipments of EndoFLIP® product in European market

Monday 6th July 2009 – Crospon, a medical device developer based in Galway, Ireland, today
announced it has completed the first shipment of its flagship gastroenterology product,
EndoFLIP® to the European market.

Following the announcement of a worldwide distribution deal in May with Dutch company,
Medical Measurement Systems, Crospon has completed its start-up activities for EndoFLIP® and
has now gone into commercial production.

Crospon develops leading edge minimally invasive medical devices for monitoring, diagnosis and
therapy in the gastroenterology area.

Announcing the completion of the first shipment, John O’Dea, CEO, Crospon said, “The
shipment marks a real milestone both Crospon and EndoFLIP®. We as a team at Crospon have
been working towards this target for the last two years. I would like to take this opportunity to
thank all of the staff at Crospon who have each played an integral part in bringing the company
to this point. We look forward taking to the next steps in extending the application of the
EndoFLIP® platform technology into the Bariatric Surgery marketplace in the coming year.”

The EndoFLIP® tool which is pending FDA approval was designed by Crospon to provide a more
physiologically relevant diagnostic test for gastroesophageal reflux disease (GERD). Chronic
GERD is a prevalent disorder reaching epidemic proportions worldwide that manifests itself as
severe heartburn caused by stomach acid refluxing up into the oesophagus.

Crospon’s development of the EndoFLIP® system was recently recognised with the 2009
European Gastroenterology Technology Implementation of the Year Award, by Frost & Sullivan.

In January, Crospon announced that its EndoFLIP® system had received CE Mark certification
from the NSAI (National Standards Authority of Ireland), the Irish notified body in accordance
with the European Medical Device Directive. The Company also announced the appointment of
Larry Fulton as Vice President of Sales –Americas located at the Crospon’s newly established US
operation in Carlsbad, California.


 
Newsroom Links
News Headlines
Upcoming Events
         
EndoFLIP logo   Crospon Inc. 701 Palomar Airport Rd, Carlsbad, CA 92011, USA. Phone: 1-855-CROSPON
Crospon Ireland. Galway Business Park, Dangan, Galway, Ireland Phone: +353-91-519880